Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Annals of the Rheumatic Diseases|December 1, 1978
Lateral subluxation of the atlanto-axial joint in rheumatoid arthritisH C Burry, J M Tweed, R G Robinson, et al.The Clinical Teacher|August 10, 2019
Student belief about the value of challengeJ R Rudland, C Golding, C Jaye, et al.Annals of the Rheumatic Diseases|March 1, 1987
Psoriatic arthritis: clinical subgroups and histocompatibility antigensN J McHugh, M R Laurent, B L Treadwell, et al.Journal of Animal Science|March 1, 1994
Composition, preservation, and use of sea clam viscera as a protein supplement for growing pigsJ E Wohlt, J Petro, G M Horton, et al.The New Zealand Medical Journal|December 14, 1983
Nabumetone, a new non-steroidal anti-inflammatory drug: a comparison with naproxenA M Richards, H C Burry, B L Treadwell, et al.International Journal of Oncology|March 2, 2022
Antagonism of the transient receptor potential melastatin‑2 channel leads to targeted antitumor effects in primary human malignant melanoma cellsShelby G McKamey, Lukas R Jira, Christopher M Tweed, et al.Bioorganic & Medicinal Chemistry Letters|May 18, 1999
The discovery of orally available thrombin inhibitors: optimisation of the P1 pharmacophoreJ Ambler, D Bentley, L Brown, et al.Journal of Biomedical Materials Research. Part A|January 11, 2008
Uptake of calcium phosphate nanoshells by osteoblasts and their effect on growth and differentiationStephanie M Schmidt, Kathleen A Moran, Ailis M Tweed Kent, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 1999
The discovery of orally available thrombin inhibitors: studies towards the optimisation of CGH1668J Ambler, E Baker, L Brown, et al.Bioorganic & Medicinal Chemistry Letters|July 29, 2000
The design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitorsJ Hayler, P D Kane, D LeGrand, et al.Pageof 3